id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
bionys-549	A., Nagarajan; C., Vignesh; T., Ramasamy; M., Sasikala; S., Mohan	Beyond boundaries: pioneering discoveries in aldose reductase inhibition for diabetic neuropathy	2024	12	.pdf	application/pdf	6351	295	52	The results from in vitro studies show a potent dose-dependent inhibitory activity for aldose reductase at 22.77 μM. Given the recent emphasis on identifying effective aldose reductase inhibitors, our results represent a starting point for the extensive research needed to achieve this goal. Using molecular simulation and docking Bakal et al. (2022) identified (Z)-2-(5-((1-methoxynaphthalen- 2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl) acetic acid derivative as aldose reductase inhibitor (Fig. 1).	cache/bionys-549.pdf	txt/bionys-549.txt